Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)
We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the ph...
Gespeichert in:
Veröffentlicht in: | Journal of veterinary pharmacology and therapeutics 2005-02, Vol.28 (1), p.21-27 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 27 |
---|---|
container_issue | 1 |
container_start_page | 21 |
container_title | Journal of veterinary pharmacology and therapeutics |
container_volume | 28 |
creator | Maslow, J.N Mikota, S.K Zhu, M Isaza, R Peddie, L.R Dunker, F Peddie, J Riddle, H Peloquin, C.A |
description | We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form. |
doi_str_mv | 10.1111/j.1365-2885.2004.00619.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67444772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67444772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhiMEokvhFcAnBIcsYyeOE4nLqioFtEARtBwtJ5m03ib2Yjtil8fhSXE2q3LFF_-a-f4Zy3-SEApLGs-bzZJmBU9ZWfIlA8iXAAWtlrsHyeK-8TBZAM0hFaLMTpIn3m8AICspfZycUC4YcEoXyZ9Lux17FbQ1ZHur3KAae6cNBt14YjuivTVa_dYt0YaEWyTBoQoDmjB1P-0bW6smoNPjQMJYo2vG3nrtiRqsuSErr5UhyrRk1TndRI09xj0mePLq_CA9GdROD6M_YGu7s601QRE1G9Trp8mjTvUenx3v0-Tq3fn3s_fp-svFh7PVOm1yVlZphh1jUACtoChRgaACO9HUBeW54Mg5KOBQVwVgFeulKJgQ2LKiyDOAimenyct57tbZnyP6IAftG-x7ZdCOXhYiz3MhWATLGWyc9d5hJ7dOD8rtJQU55SM3copBTjHIKR95yEfuovX5ccdYD9j-Mx4DicDbGfile9z_92D58foyimhPZ7v2AXf3duXu4vMzweWPzxeyzKqvrMyEvI78i5nvlJXqxmkvr74xoNOPVDlnkP0Fyou4qA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67444772</pqid></control><display><type>article</type><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</creator><creatorcontrib>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</creatorcontrib><description>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</description><identifier>ISSN: 0140-7783</identifier><identifier>EISSN: 1365-2885</identifier><identifier>DOI: 10.1111/j.1365-2885.2004.00619.x</identifier><identifier>PMID: 15720511</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Administration, Oral ; Administration, Rectal ; Animals ; Antitubercular Agents - administration & dosage ; Antitubercular Agents - blood ; Antitubercular Agents - pharmacokinetics ; Antitubercular Agents - therapeutic use ; Area Under Curve ; bacterial infections ; dosage ; drug formulations ; drug therapy ; Elephants - metabolism ; Elephas maximus ; Female ; isoniazid ; Isoniazid - administration & dosage ; Isoniazid - blood ; Isoniazid - pharmacokinetics ; Isoniazid - therapeutic use ; Loxodonta africana ; Male ; Mycobacterium tuberculosis ; oral administration ; pharmacokinetics ; powders ; rectal administration ; rectum ; tuberculosis ; Tuberculosis - drug therapy ; Tuberculosis - veterinary</subject><ispartof>Journal of veterinary pharmacology and therapeutics, 2005-02, Vol.28 (1), p.21-27</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</citedby><cites>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2885.2004.00619.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2885.2004.00619.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15720511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maslow, J.N</creatorcontrib><creatorcontrib>Mikota, S.K</creatorcontrib><creatorcontrib>Zhu, M</creatorcontrib><creatorcontrib>Isaza, R</creatorcontrib><creatorcontrib>Peddie, L.R</creatorcontrib><creatorcontrib>Dunker, F</creatorcontrib><creatorcontrib>Peddie, J</creatorcontrib><creatorcontrib>Riddle, H</creatorcontrib><creatorcontrib>Peloquin, C.A</creatorcontrib><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><title>Journal of veterinary pharmacology and therapeutics</title><addtitle>J Vet Pharmacol Ther</addtitle><description>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</description><subject>Administration, Oral</subject><subject>Administration, Rectal</subject><subject>Animals</subject><subject>Antitubercular Agents - administration & dosage</subject><subject>Antitubercular Agents - blood</subject><subject>Antitubercular Agents - pharmacokinetics</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Area Under Curve</subject><subject>bacterial infections</subject><subject>dosage</subject><subject>drug formulations</subject><subject>drug therapy</subject><subject>Elephants - metabolism</subject><subject>Elephas maximus</subject><subject>Female</subject><subject>isoniazid</subject><subject>Isoniazid - administration & dosage</subject><subject>Isoniazid - blood</subject><subject>Isoniazid - pharmacokinetics</subject><subject>Isoniazid - therapeutic use</subject><subject>Loxodonta africana</subject><subject>Male</subject><subject>Mycobacterium tuberculosis</subject><subject>oral administration</subject><subject>pharmacokinetics</subject><subject>powders</subject><subject>rectal administration</subject><subject>rectum</subject><subject>tuberculosis</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - veterinary</subject><issn>0140-7783</issn><issn>1365-2885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAQhiMEokvhFcAnBIcsYyeOE4nLqioFtEARtBwtJ5m03ib2Yjtil8fhSXE2q3LFF_-a-f4Zy3-SEApLGs-bzZJmBU9ZWfIlA8iXAAWtlrsHyeK-8TBZAM0hFaLMTpIn3m8AICspfZycUC4YcEoXyZ9Lux17FbQ1ZHur3KAae6cNBt14YjuivTVa_dYt0YaEWyTBoQoDmjB1P-0bW6smoNPjQMJYo2vG3nrtiRqsuSErr5UhyrRk1TndRI09xj0mePLq_CA9GdROD6M_YGu7s601QRE1G9Trp8mjTvUenx3v0-Tq3fn3s_fp-svFh7PVOm1yVlZphh1jUACtoChRgaACO9HUBeW54Mg5KOBQVwVgFeulKJgQ2LKiyDOAimenyct57tbZnyP6IAftG-x7ZdCOXhYiz3MhWATLGWyc9d5hJ7dOD8rtJQU55SM3copBTjHIKR95yEfuovX5ccdYD9j-Mx4DicDbGfile9z_92D58foyimhPZ7v2AXf3duXu4vMzweWPzxeyzKqvrMyEvI78i5nvlJXqxmkvr74xoNOPVDlnkP0Fyou4qA</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Maslow, J.N</creator><creator>Mikota, S.K</creator><creator>Zhu, M</creator><creator>Isaza, R</creator><creator>Peddie, L.R</creator><creator>Dunker, F</creator><creator>Peddie, J</creator><creator>Riddle, H</creator><creator>Peloquin, C.A</creator><general>Blackwell Science Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><author>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Administration, Oral</topic><topic>Administration, Rectal</topic><topic>Animals</topic><topic>Antitubercular Agents - administration & dosage</topic><topic>Antitubercular Agents - blood</topic><topic>Antitubercular Agents - pharmacokinetics</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Area Under Curve</topic><topic>bacterial infections</topic><topic>dosage</topic><topic>drug formulations</topic><topic>drug therapy</topic><topic>Elephants - metabolism</topic><topic>Elephas maximus</topic><topic>Female</topic><topic>isoniazid</topic><topic>Isoniazid - administration & dosage</topic><topic>Isoniazid - blood</topic><topic>Isoniazid - pharmacokinetics</topic><topic>Isoniazid - therapeutic use</topic><topic>Loxodonta africana</topic><topic>Male</topic><topic>Mycobacterium tuberculosis</topic><topic>oral administration</topic><topic>pharmacokinetics</topic><topic>powders</topic><topic>rectal administration</topic><topic>rectum</topic><topic>tuberculosis</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - veterinary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maslow, J.N</creatorcontrib><creatorcontrib>Mikota, S.K</creatorcontrib><creatorcontrib>Zhu, M</creatorcontrib><creatorcontrib>Isaza, R</creatorcontrib><creatorcontrib>Peddie, L.R</creatorcontrib><creatorcontrib>Dunker, F</creatorcontrib><creatorcontrib>Peddie, J</creatorcontrib><creatorcontrib>Riddle, H</creatorcontrib><creatorcontrib>Peloquin, C.A</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maslow, J.N</au><au>Mikota, S.K</au><au>Zhu, M</au><au>Isaza, R</au><au>Peddie, L.R</au><au>Dunker, F</au><au>Peddie, J</au><au>Riddle, H</au><au>Peloquin, C.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</atitle><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle><addtitle>J Vet Pharmacol Ther</addtitle><date>2005-02</date><risdate>2005</risdate><volume>28</volume><issue>1</issue><spage>21</spage><epage>27</epage><pages>21-27</pages><issn>0140-7783</issn><eissn>1365-2885</eissn><abstract>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15720511</pmid><doi>10.1111/j.1365-2885.2004.00619.x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-7783 |
ispartof | Journal of veterinary pharmacology and therapeutics, 2005-02, Vol.28 (1), p.21-27 |
issn | 0140-7783 1365-2885 |
language | eng |
recordid | cdi_proquest_miscellaneous_67444772 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Administration, Oral Administration, Rectal Animals Antitubercular Agents - administration & dosage Antitubercular Agents - blood Antitubercular Agents - pharmacokinetics Antitubercular Agents - therapeutic use Area Under Curve bacterial infections dosage drug formulations drug therapy Elephants - metabolism Elephas maximus Female isoniazid Isoniazid - administration & dosage Isoniazid - blood Isoniazid - pharmacokinetics Isoniazid - therapeutic use Loxodonta africana Male Mycobacterium tuberculosis oral administration pharmacokinetics powders rectal administration rectum tuberculosis Tuberculosis - drug therapy Tuberculosis - veterinary |
title | Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A39%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Population%20pharmacokinetics%20of%20isoniazid%20in%20the%20treatment%20of%20Mycobacterium%20tuberculosis%20among%20Asian%20and%20African%20elephants%20(Elephas%20maximus%20and%20Loxodonta%20africana)&rft.jtitle=Journal%20of%20veterinary%20pharmacology%20and%20therapeutics&rft.au=Maslow,%20J.N&rft.date=2005-02&rft.volume=28&rft.issue=1&rft.spage=21&rft.epage=27&rft.pages=21-27&rft.issn=0140-7783&rft.eissn=1365-2885&rft_id=info:doi/10.1111/j.1365-2885.2004.00619.x&rft_dat=%3Cproquest_cross%3E67444772%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67444772&rft_id=info:pmid/15720511&rfr_iscdi=true |